Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.9M Sell
129,406
-2,659
-2% -$910K 0.56% 37
2026
Q1
$46.5M Sell
132,065
-2,350
-2% -$838K 0.78% 28
2025
Q4
$44M Buy
134,415
+6,216
+5% +$1.97M 0.75% 27
2025
Q3
$36.2M Sell
128,199
-110
-0.1% -$31.9K 0.66% 30
2025
Q2
$35.8M Buy
128,309
+3,290
+3% +$932K 0.72% 25
2025
Q1
$38.9M Buy
125,019
+3,237
+3% +$956K 0.91% 19
2024
Q4
$31.7M Buy
+121,782
New +$36.1M 0.69% 29

Other funds holding AMGN

GF Fund Management's AMGN Position: Q2 2026 in Review

GF Fund Management reduced its Amgen (AMGN) stake by 2% in Q2 2026, selling an estimated $910K and leaving 129,406 shares worth $46.9M. The position accounts for 0.56% of the portfolio, ranked #37.

GF Fund Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • GF Fund Management held 129,406 shares of Amgen worth $46.9M as of Q2 2026.
  • GF Fund Management sold 2,659 Amgen shares in Q2 2026, an estimated $910K.
  • Amgen made up 0.56% of GF Fund Management's portfolio in Q2 2026, its #37 holding.
  • GF Fund Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.